Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
RANDOMIZED CONTROLLED TRIAL
Caius Mihai Breazu, Alexandru Leonard Alexa, Oana Urs, Voicu Mercea, Marcel Tantau, Adrian Bartos, Lidia Ciobanu, Daniela Ionescu
BACKGROUND: Sedation of elderly patients with associated comorbidities, subjected to ERCP procedure, can produce serious complications including respiratory instability and hemodynamics caused by the administration of anesthetic substances. In this study we aimed to evaluate whether the administration of lidocaine in continuous infusion during ERCP procedure reduces the consumption of propofol and the rate of complications in these patients. METHODS: 83 patients over 65-year old, ASA II-IV score, undergoing an ERCP procedure were randomized in two groups: lidocaine group (group L) who received 1...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#2
JOURNAL ARTICLE
Kilian Weigand, Georg Peschel, Jonathan Grimm, Martina Müller, Christa Buechler
BACKGROUND AND AIMS: Serum galectin-3 is regarded as an inflammatory marker in patients with chronic liver diseases. Hepatitis C virus (HCV) infection is associated with higher levels of inflammatory molecules which ameliorate by efficient treatment with direct-acting antivirals (DAAs). The aim of this study was to compare serum galectin-3 levels between HCV patients before treatment with DAAs and at the time of sustained virologic response at 12 weeks post-treatment (SVR12). METHODS: Hepatitis B and human immunodeficiency virus-negative HCV infected patients not treated with HCV therapies before were recruited at the University Hospital of Regensburg...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#3
JOURNAL ARTICLE
Liana Gheorghe, Carmen Preda, Anca Trifan, Mircea Manuc, Carol Stanciu, Doina Istratescu, Corneliu Petru Popescu, Mircea Mihai Diculescu, Cristian George Tieranu, Teodora Manuc, Tudor Gheorghe Stroie, Speranta Maria Iacob, Laura Iliescu
BACKGROUND AND AIMS: The sofosbuvir (SOF) / velpatasvir (VEL) / voxilaprevir (VOX) combination has been evaluated in more than 800 patients enrolled in phase II and phase III studies, where it demonstrated excellent safety and efficacy, achieving overall sustained viral response (SVR) rates of more than 95%. We aimed to assess the efficacy and safety of SOF/VEL/VOX in a real-world study, including patients previously treated for genotype 1b hepatitis C virus (HCV) infection that did not obtain a sustained viral response with previous direct-acting antivirals (DAAs) therapy...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#4
JOURNAL ARTICLE
Michiaki Higashitani, Atsushi Mizuno, Takeshi Kimura, Takuro Shimbo, Kazuki Yamamoto, Sayuri Tokioka, Daiki Kobayashi
AIMS: This study aimed to evaluate the association between aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio and cardiovascular disease, and risk factors in a healthy Japanese population. METHODS: A retrospective cohort study was conducted at St. Luke's International Hospital, Tokyo, Japan, between 2005 and 2018. We included all participants who visited the hospital for voluntary health checkups. Our primary outcome was the development of cardiovascular disease, and the secondary outcomes were cardiovascular risk factors...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#5
JOURNAL ARTICLE
Nicole Sciberras, Anthea Pisani, Vanessa Vella, Eliezer Zahra Bianco, Claire Vassallo, Pierre Ellul
BACKGROUND AND AIMS: This study assessed the differences in swabbing rates, vaccine uptake, COVID-19 infection, hospitalization rates and outcomes in patients suffering from inflammatory bowel disease (IBD) on immunomodulation and patients diagnosed with irritable bowel syndrome (IBS). METHODS: A population consisting of 250 IBD and 250 IBS patients was randomly selected from the local database. Apart from demographic data, the following data was collected: number of COVID-19 swabs taken, vaccination rates, type of vaccine administered, infection secondary to COVID-19, hospitalization and outcomes...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#6
JOURNAL ARTICLE
Hulya Kamarli Altun, Emine Akal Yildiz, Mete Akin
BACKGROUND AND AIMS: Ulcerative colitis is a chronic inflammatory disease which is affecting the quality of life, workforce and nutrition of patients negatively in the active periods due to its symptoms. This study aims to explore how synbiotic treatment affects the quality of life in patients with mild-to-moderate ulcerative colitis. METHODS: Forty ulcerative colitis patients with mild-to-moderate activity were enrolled in the study. Patients were split into two even randomized groups as synbiotic (20 patients) and control (20 patients)...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#7
LETTER
Alexander Kusnik, Mostafa Reda Mostafa, Nicole Hunter, Rutwik Sharma, Hera Jamal, Mazin Hameed
No abstract text is available yet for this article.
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#8
LETTER
Mariapaola Piazzolla, Antonia Valeria Borraccino, Salvatore Rizzi, Giuseppe Losurdo, Alfredo Di Leo
No abstract text is available yet for this article.
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#9
LETTER
Nik Arsyad Nik Muhamad Affendi, Choon Jin Ooi, Ida Normiha Hilmi
No abstract text is available yet for this article.
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#10
LETTER
Merve Eren Durmuş, Serkan Öcal, Adil Duman, Ruhsen Öcal, Gökhan Köker
No abstract text is available yet for this article.
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#11
LETTER
Emanuel Dias, João Santos-Antunes, Armando Peixoto, Rosa Ramalho, Guilherme Macedo
No abstract text is available yet for this article.
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#12
Hao-Zhen Ye, Ben Wang, He Zhou, Jia-Jia Gao, Zhi-Wei Li, Hong-Wei Xu
AIM: The aim of our systematic review and meta-analysis was to assess the risk of postpolypectomy bleeding (PPB) in patients exposed to direct oral anticoagulants (DOACs). METHODS: A systematic search was conducted by searching the PubMed, Embase, and Cochrane Library databases using the following search terms: "(nonvitamin K antagonist oral anticoagulants or NOAC or apixaban or dabigatran or rivaroxaban or edoxaban or DOAC or direct oral anticoagulants) and polypectomy"...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#13
Ilias Giannakodimos, Alexios Giannakodimos, Afroditi Ziogou, Maximos Frountzas, Neoklis Kritikos, Konstantinos Vlachos, Konstantinos G Toutouzas, Dimitrios Schizas
BACKGROUND AND AIMS: Somatostatinoma of the ampulla of Vater (SAV) is a rare neuroendocrine tumor that usually appears with atypical clinical manifestations and is associated with Von Recklinghausen's disease. The aims of this study were to systematically review the literature regarding SAV and to highlight the clinicopathological characteristics and optimal therapeutic management of this rare entity. METHODS: A systematic search of the literature in PubMed/Medline and Scopus databases was performed by two independent investigators, including all case reports and case series concerning SAVs from 1980 until September 2021...
December 17, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#14
JOURNAL ARTICLE
Antonio Tursi, Giammarco Mocci, Antonio Cuomo, Antonio Ferronato, Walter Elisei, Marcello Picchio, Giovanni Maconi, Franco Scaldaferri, Alfredo Papa, Leonardo Allegretta, Giovanni Aragona, Maria Antonia Bianco, Raffaele Colucci, Nicola Della Valle, Roberto Faggiani, Giacomo Forti, Federica Gaiani, GianMarco Giorgetti, Maria Giovanna Graziani, Katia Lofano, Roberto Lorenzetti, Tiziana Larussa, Antonio Penna, Gabrio Bassotti, Alessia Immacolata Cazzato, Stefania Chiri, Valeria Clemente, Andrea Cocco, Gianluigi De' Angelis, Laura Donnarumma, Camilla Graziosi, Marco Le Grazie, Francesco Luzza, Costantino Meucci, Rita Monterubbianesi, Cristiano Pagnini, Patrizia Perazzo, Roberta Pica, Giuseppe Pranzo, Stefano Rodino', Rodolfo Sacco, Ladislava Sebkova, Antonella Scarcelli, Mariaelena Serio, Daniele Napolitano, Daniela Pugliese, Elisa Schiavoni, Laura Turchini, Alessandro Armuzzi, Costantino Zampaletta
BACKGROUND AND AIMS: Adalimumab (ADA) biosimilars have been included into the therapeutic armamentarium of inflammatory bowel disease (IBD); however, comparative data on the efficacy and safety of the different ADA biosimilars after replacing the ADA originator for a non-medical reason remains scarce. We aimed to compare in a real-life setting the efficacy and safety of four ADA biosimilars SB5, APB501, GP2017, and MSB11022 in IBD patients after replacing the originator for a non-medical reason...
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#15
JOURNAL ARTICLE
Panu Wetwittayakhlang, Petra A Golovics, Alex Al Khoury, Elie Ganni, Gustavo Drügg Hahn, Albert Cohen, Jonathan Wyse, Marc Bradette, Talat Bessissow, Waqqas Afif, Gary Wild, Alain Bitton, Peter Laszlo Lakatos
BACKGROUND AND AIMS: Objective monitoring and effective early treatment using a treat-to-target approach are key to improving therapeutic outcomes in IBD patients. This study aimed to assess adherence to objective monitoring (clinical, biomarkers, and endoscopy) and its impact on clinical outcomes. METHODS: A prospective, multicenter study included consecutive IBD patients starting on adalimumab therapy between January 2019 and December 2020. Disease activity, assessed by the Harvey-Bradshaw index (HBI), partial Mayo, C-reactive protein (CRP), fecal calprotectin (FCAL), and endoscopy were evaluated at adalimumab initiation and 3, 6, 9 and 12 months...
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#16
JOURNAL ARTICLE
Kazunari Nakahara, Junya Sato, Keisuke Tateishi
No abstract text is available yet for this article.
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#17
JOURNAL ARTICLE
Aida Puia, Diana Schlanger, Alin Fetti, Calin Popa, Alexandru Necula, Nadim Al Hajjar
BACKGROUND AND AIMS: Gastric cancer is one of the most common malignancies, with an aggressive evolution and a poor long-term prognosis. No screening program is available in Europe for this pathology; therefore, the delay from the appearance of the first symptom until the initiation of treatment might influence the prognosis of gastric cancer patients. We aimed to investigate the impact on the prognosis of the delay in the presentation and diagnosis in patients with gastric adenocarcinoma...
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#18
JOURNAL ARTICLE
Dario Gambaccini, Luigi Ruggiero, Emanuele Marciano
No abstract text is available yet for this article.
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#19
JOURNAL ARTICLE
Taiga Chiyo, Hideki Kobara, Noriko Nishiyama, Kaho Nakatani, Naoya Tada, Kazuhiro Koduka, Takanori Matsui, Nobuya Kobayashi, Shintaro Fujihara, Tatsuo Yachida, Tsutomu Masaki
BACKGROUND AND AIMS: The most suitable procedure for resecting small-sized gastric neoplasms remains unclear. Endoscopic mucosal resection leads to non-curative resection owing to slippage of the snare, and technically difficult endoscopic submucosal dissection (ESD) is instrumentally uneconomical. A novel, cost-effective, multifunctional snare called SOUTEN is available as a hybrid ESD (h-ESD) device developed for facilitating ESD. This study aimed to assess the acceptability of h-ESD using the SOUTEN for resecting small-sized gastric neoplasms...
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
#20
JOURNAL ARTICLE
Isabel Garrido, Eduardo Rodrigues-Pinto, Irene Gullo, Guilherme Macedo
No abstract text is available yet for this article.
December 16, 2022: Journal of Gastrointestinal and Liver Diseases: JGLD
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
